OKYOOKYO Pharma Limited American Depositary Shares
1.540USDMkt Cap: 80.82M $P/E: —3d ago
OKYO Pharma Limited, a clinical-stage biopharmaceutical company, develops therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead clinical product candidate is u…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap80.82M $
Enterprise Value59.17M $
Revenue (TTM)—
Gross Profit-6.69M $
Net Income (TTM)-8.95M $
Revenue/Share—
Last Price1.540 USD
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees5
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.30
PEG—
EV/EBITDA-6.96
EV/Revenue—
P/S—
P/B6.47
EPS (TTM)-0.24
EPS (Forward)-0.66
52W Range
1.52050% of range1.560
52W High1.560 USD
52W Low1.520 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-72.55%
ROA-42.67%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.94M $
CapEx (TTM)6.08K $
FCF Margin—
FCF Yield-2.60%
Net Debt-20.59M $
Net Debt/EBITDA2.42
Balance Sheet
Debt/Equity—
Current Ratio2.43
Quick Ratio2.40
Book Value/Sh0.2350 USD
Cash/Share0.3920 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)8.333 USD
Upside (mean)+441.1%
Target Range5.000 USD – 13.00 USD
$5.000+441.1% to mean$13.00
# Analysts3
Ownership
Shares Out.52.48M
Float27.93M
Insiders31.03%
Institutions20.12%
Short Interest
Short Ratio0.8d
Short % Float0.32%
Short % Out.0.26%
Shares Short135.37K
Short (prev mo.)32.38K
Technical
SMA 501.553 (-0.9%)
SMA 2001.811 (-14.9%)
Beta0.02
S&P 52W Chg21.00%
Avg Vol (30d)14.67K
Avg Vol (10d)89.39K
Technical Indicators
RSI (14)49.1
MACD-0.0138
MACD Signal-0.0108
MACD Hist.-0.0030
BB Upper1.702 USD
BB Middle1.569 USD
BB Lower1.437 USD
BB Width16.88%
ATR (14)0.0866 USD
Vol Ratio (20d)0.20x